{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T09:04:51Z","timestamp":1791450291244,"version":"4.3.3"},"reference-count":33,"publisher":"American Medical Association (AMA)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Neurol"],"published-print":{"date-parts":[[2020,1,1]]},"DOI":"10.1001\/jamaneurol.2019.2940","type":"journal-article","created":{"date-parts":[[2019,9,23]],"date-time":"2019-09-23T11:30:44Z","timestamp":1569238244000},"page":"82","source":"Crossref","is-referenced-by-count":323,"title":["Serial Anti\u2013Myelin Oligodendrocyte Glycoprotein Antibody Analyses and Outcomes in Children With Demyelinating Syndromes"],"prefix":"10.1001","volume":"77","author":[{"given":"Patrick","family":"Waters","sequence":"first","affiliation":[{"name":"Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Fadda","sequence":"additional","affiliation":[{"name":"Perelman Center for Advanced Medicine, Department of Neurology, University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Woodhall","sequence":"additional","affiliation":[{"name":"Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"O\u2019Mahony","sequence":"additional","affiliation":[{"name":"Institute of Health Policy, Management and Evaluation, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Brown","sequence":"additional","affiliation":[{"name":"Montreal Neurological Institute, McGill University, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise A.","family":"Castro","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Imaging, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Longoni","sequence":"additional","affiliation":[{"name":"Hospital for Sick Children Research Institute, Division of Neurology, Department of Pediatrics, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarosh R.","family":"Irani","sequence":"additional","affiliation":[{"name":"Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Sun","sequence":"additional","affiliation":[{"name":"Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Ann","family":"Yeh","sequence":"additional","affiliation":[{"name":"Hospital for Sick Children Research Institute, Division of Neurology, Department of Pediatrics, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth Ann","family":"Marrie","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Rady Faculty of Health Sciences, Max Rady College of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada"},{"name":"Department of Community Health Sciences, Rady Faculty of Health Sciences, Max Rady College of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas L.","family":"Arnold","sequence":"additional","affiliation":[{"name":"Montreal Neurological Institute, McGill University, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenda","family":"Banwell","sequence":"additional","affiliation":[{"name":"Division of Neurology, The Children\u2019s Hospital of Philadelphia, Philadelphia, Pennsylvania"},{"name":"Center for Neuroinflammation and Experimental Therapeutics, University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Bar-Or","sequence":"additional","affiliation":[{"name":"Perelman Center for Advanced Medicine, Department of Neurology, University of Pennsylvania, Philadelphia"},{"name":"Montreal Neurological Institute, McGill University, Montreal, Quebec, Canada"},{"name":"Division of Neurology, The Children\u2019s Hospital of Philadelphia, Philadelphia, Pennsylvania"},{"name":"Center for Neuroinflammation and Experimental Therapeutics, University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the Canadian Pediatric Demyelinating Disease Network","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"2","key":"noi190075r1","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/s41582-018-0112-x","article-title":"Myelin oligodendrocyte glycoprotein antibodies in neurological disease.","volume":"15","author":"Reindl","year":"2019","journal-title":"Nat Rev Neurol"},{"issue":"2","key":"noi190075r2","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1177\/1352458515587751","article-title":"Clinical and MRI phenotype of children with MOG antibodies.","volume":"22","author":"Fernandez-Carbonell","year":"2016","journal-title":"Mult Scler"},{"issue":"9","key":"noi190075r3","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1212\/WNL.0000000000004312","article-title":"Prognostic relevance of MOG antibodies in children with an acquired demyelinating syndrome.","volume":"89","author":"Hennes","year":"2017","journal-title":"Neurology"},{"issue":"7","key":"noi190075r4","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1177\/1352458514555785","article-title":"Antibodies to MOG and AQP4 in adults with neuromyelitis optica and suspected limited forms of the disease.","volume":"21","author":"H\u00f6ftberger","year":"2015","journal-title":"Mult Scler"},{"issue":"7","key":"noi190075r5","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1007\/s00415-016-8147-7","article-title":"Clinical spectrum associated with MOG autoimmunity in adults: significance of sharing rodent MOG epitopes.","volume":"263","author":"Sep\u00falveda","year":"2016","journal-title":"J Neurol"},{"issue":"10","key":"noi190075r6","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1136\/jnnp-2017-315998","article-title":"Longitudinal analysis of myelin oligodendrocyte glycoprotein antibodies in CNS inflammatory diseases.","volume":"88","author":"Hyun","year":"2017","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"noi190075r7","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1186\/s12974-016-0718-0","article-title":"MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. part 2: epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome.","volume":"13","author":"Jarius","year":"2016","journal-title":"J Neuroinflammation"},{"issue":"3","key":"noi190075r8","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1111\/ene.2016.23.issue-3","article-title":"Neuromyelitis optica spectrum disorders: comparison of clinical and magnetic resonance imaging characteristics of AQP4-IgG versus MOG-IgG seropositive cases in the Netherlands.","volume":"23","author":"van Pelt","year":"2016","journal-title":"Eur J Neurol"},{"issue":"9","key":"noi190075r9","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1111\/dmcn.13703","article-title":"Myelin oligodendrocyte glycoprotein and aquaporin-4 antibodies are highly specific in children with acquired demyelinating syndromes.","volume":"60","author":"Duignan","year":"2018","journal-title":"Dev Med Child Neurol"},{"issue":"11","key":"noi190075r10","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1001\/jamaneurol.2018.1814","article-title":"Association of MOG-IgG serostatus with relapse after acute disseminated encephalomyelitis and proposed diagnostic criteria for MOG-IgG-associated disorders.","volume":"75","author":"L\u00f3pez-Chiriboga","year":"2018","journal-title":"JAMA Neurol"},{"issue":"8","key":"noi190075r11","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1177\/1352458512470310","article-title":"Persisting myelin oligodendrocyte glycoprotein antibodies in aquaporin-4 antibody negative pediatric neuromyelitis optica.","volume":"19","author":"Rost\u00e1sy","year":"2013","journal-title":"Mult Scler"},{"issue":"16, suppl 2","key":"noi190075r12","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.1212\/01.wnl.0000259422.44235.a8","article-title":"Consensus definitions proposed for pediatric multiple sclerosis and related disorders.","volume":"68","author":"Krupp","year":"2007","journal-title":"Neurology"},{"issue":"2","key":"noi190075r13","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1002\/ana.22366","article-title":"Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria.","volume":"69","author":"Polman","year":"2011","journal-title":"Ann Neurol"},{"issue":"2","key":"noi190075r14","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders.","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"issue":"1","key":"noi190075r15","doi-asserted-by":"publisher","first-page":"e115","DOI":"10.1542\/peds.2015-0028","article-title":"Recovery from central nervous system acute demyelination in children.","volume":"136","author":"O\u2019Mahony","year":"2015","journal-title":"Pediatrics"},{"issue":"3","key":"noi190075r16","doi-asserted-by":"publisher","first-page":"e89","DOI":"10.1212\/NXI.0000000000000089","article-title":"MOG cell-based assay detects non-MS patients with inflammatory neurologic disease.","volume":"2","author":"Waters","year":"2015","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"9","key":"noi190075r17","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1136\/jnnp-2015-312601","article-title":"Multicentre comparison of a diagnostic assay: aquaporin-4 antibodies in neuromyelitis optica.","volume":"87","author":"Waters","year":"2016","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"12","key":"noi190075r18","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1016\/S1474-4422(11)70250-2","article-title":"MRI parameters for prediction of multiple sclerosis diagnosis in children with acute CNS demyelination: a prospective national cohort study.","volume":"10","author":"Verhey","year":"2011","journal-title":"Lancet Neurol"},{"issue":"3","key":"noi190075r19","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S2352-4642(18)30026-9","article-title":"MRI and laboratory features and the performance of international criteria in the diagnosis of multiple sclerosis in children and adolescents: a prospective cohort study.","volume":"2","author":"Fadda","year":"2018","journal-title":"Lancet Child Adolesc Health"},{"issue":"3","key":"noi190075r20","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1007\/s11222-016-9646-1","article-title":"Correlation and variable importance in random forests.","volume":"27","author":"Gregorutti","year":"2017","journal-title":"Stat Comput"},{"issue":"12","key":"noi190075r21","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1177\/1352458514566666","article-title":"Anti-MOG antibodies plead against MS diagnosis in an acquired demyelinating syndromes cohort.","volume":"21","author":"Ketelslegers","year":"2015","journal-title":"Mult Scler"},{"issue":"8","key":"noi190075r22","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1136\/jnnp-2015-311743","article-title":"Antibodies to MOG and AQP4 in children with neuromyelitis optica and limited forms of the disease.","volume":"87","author":"Lechner","year":"2016","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"14","key":"noi190075r23","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1177\/1352458516631038","article-title":"Children with multiphasic disseminated encephalomyelitis and antibodies to the myelin oligodendrocyte glycoprotein (MOG): extending the spectrum of MOG antibody positive diseases.","volume":"22","author":"Baumann","year":"2016","journal-title":"Mult Scler"},{"issue":"6","key":"noi190075r24","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1001\/archneurol.2011.2956","article-title":"Anti-myelin oligodendrocyte glycoprotein antibodies in pediatric patients with optic neuritis.","volume":"69","author":"Rostasy","year":"2012","journal-title":"Arch Neurol"},{"issue":"4","key":"noi190075r25","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1007\/s00415-018-8781-3","article-title":"MRI of the first event in pediatric acquired demyelinating syndromes with antibodies to myelin oligodendrocyte glycoprotein.","volume":"265","author":"Baumann","year":"2018","journal-title":"J Neurol"},{"issue":"2","key":"noi190075r26","doi-asserted-by":"publisher","first-page":"e81","DOI":"10.1212\/NXI.0000000000000081","article-title":"Myelin oligodendrocyte glycoprotein antibodies are associated with a non-MS course in children.","volume":"2","author":"Hacohen","year":"2015","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"2","key":"noi190075r27","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1136\/jnnp-2017-316880","article-title":"Clinical course, therapeutic responses and outcomes in relapsing MOG antibody-associated demyelination.","volume":"89","author":"Ramanathan","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"21","key":"noi190075r28","doi-asserted-by":"publisher","first-page":"e1858","DOI":"10.1212\/WNL.0000000000005560","article-title":"Clinical spectrum and prognostic value of CNS MOG autoimmunity in adults: the MOGADOR study.","volume":"90","author":"Cobo-Calvo","year":"2018","journal-title":"Neurology"},{"issue":"3","key":"noi190075r29","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1136\/jnnp-2014-308346","article-title":"Clinical and neuroradiological differences of paediatric acute disseminating encephalomyelitis with and without antibodies to the myelin oligodendrocyte glycoprotein.","volume":"86","author":"Baumann","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"noi190075r30","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1001\/jamaneurol.2017.4601","article-title":"Disease course and treatment responses in children with relapsing myelin oligodendrocyte glycoprotein antibody-associated disease.","volume":"75","author":"Hacohen","year":"2018","journal-title":"JAMA Neurol"},{"issue":"23","key":"noi190075r31","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.1212\/WNL.0000000000001045","article-title":"Onset of multiple sclerosis before adulthood leads to failure of age-expected brain growth.","volume":"83","author":"Aubert-Broche","year":"2014","journal-title":"Neurology"},{"issue":"3","key":"noi190075r32","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1212\/WNL.0b013e318240799a","article-title":"Reduced head and brain size for age and disproportionately smaller thalami in child-onset MS.","volume":"78","author":"Kerbrat","year":"2012","journal-title":"Neurology"},{"issue":"5","key":"noi190075r33","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1093\/brain\/awx041","article-title":"White matter changes in paediatric multiple sclerosis and monophasic demyelinating disorders.","volume":"140","author":"Longoni","year":"2017","journal-title":"Brain"}],"container-title":["JAMA Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/articlepdf\/2751256\/jamaneurology_waters_2019_oi_190075.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,13]],"date-time":"2020-01-13T11:01:35Z","timestamp":1578913295000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/fullarticle\/2751256"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,1]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaneurol.2019.2940","relation":{},"ISSN":["2168-6149"],"issn-type":[{"value":"2168-6149","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1,1]]}}}